<DOC>
	<DOCNO>NCT02107339</DOCNO>
	<brief_summary>Patients undergo major spinal surgery continue experience moderate-to-severe pain first 2-3 day follow operative procedure . Pain complicates recovery process , despite routine practice use potent opioid analgesic . The primary reason pain poorly control patient undergo major surgery commonly-used opioids produce analgesia 2-4 hour . The intermittent use drug result period time patient experience discomfort ( time nurse administers drug button patient-controlled analgesic ( PCA ) system press deliver medication ) . The use long-acting opioid may advantageous perioperative setting . Methadone opioid median duration analgesia 24-36 hour . Therefore , single dose administer operating room may reduce need pain medication improve pain control first postoperative day . The aim randomize clinical trial examine effect methadone ( compare hydromorphone ) postoperative pain management patient undergo major spine surgery</brief_summary>
	<brief_title>Methadone Hydromorphone For Spinal Surgery</brief_title>
	<detailed_description>Patients : 100 patient ( age 18-80 ) enrol clinical trial . All patient present elective posterior lumbar thoracic spinal fusion surgery eligible enrollment . Patients randomize receive either methadone hydromorphone basis computer generate random number table . Patients group receive standard clinical intraoperative dos either methadone ( 0.2 mg/kg ) hydromorphone ( 2 mg ) . An analysis patient undergo posterior lumbar fusion surgery Evanston Hospital reveal patient receive , average , approximately 2 mg hydromorphone intraoperatively . The commonly used dos methadone administer clinical study either 0.2 mg/kg dose 20 mg . Furthermore , dose also represent dosage appear approximately equipotent . Study medication prepare pharmacy , clinician blind group assignment . Two syrinx prepared patient , one contain study drug ( either methadone 0.2 mg/kg hydromorphone 2 mg ) , contain placebo ( saline ) . If patient randomize methadone group , 3 cc syringe contain 0.2 mg/kg methadone saline ( total volume 3 cc ) prepare , well 10 cc syringe contain 10 cc saline ( placebo ) . If patient randomize hydromorphone group , 3 cc syringe contain 3 cc saline ( placebo ) prepare , well 10 cc syringe contain 2 mg hydromorphone 9 cc saline ( total volume 10 cc ) . At induction anesthesia , 3 cc syringe contain either 0.2 mg/kg methadone placebo give 5 second . At conclusion surgery , 10 cc syringe either hydromorphone placebo titrate slowly per clinician 's preference . The administration anesthetic agent standardize reflect usual practice anesthesiologists Evanston Hospital ( spine protocol ) . Anesthesia standardize include propofol induction , propofol remifentanil infusion maintenance ( plus sevoflurane ) , IV acetaminophen 1000 mg last 60 minute case . On arrival postanesthesia care unit ( PACU ) , patient assess pain PACU nurse per standard protocol . Patients evaluate pain PACU arrival every 15 minute . Patients administer hydromorphone 0.25-0.5 mg pain , dos repeat patient comfortable ( pain &lt; 3 scale 0-10 ; 0=no pain 10=worst pain imaginable ) . The patient connect PCA device deliver pain medication remainder postoperative period . All postoperative management per standard surgical protocol Sample Size : The primary end-point investigation amount hydromorphone use . In clinical trial Urban et al . patient undergo complex spine surgery use standard anesthetic , average hydromorphone consumption first 24 hour 27 mg ( 18 ) . The investigator expect see least 33 % reduction hydromorphone consumption methadone group . Group sample size 39 39 achieve 91 % power detect difference 9.0 null hypothesis group mean 27.0 alternative hypothesis mean group 2 18.0 estimate group standard deviations 10.0 10.0 significance level ( alpha ) 0.01000 use two-sided two-sample t-test . The investigator plan enroll total 100 patient ensure complete collection data .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Hydromorphone</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>All patient present elective posterior lumbar thoracic spinal fusion surgery eligible enrollment . 1 . Preoperative renal failure ( define serum creatinine &gt; 2.0 mg/dL . ) 2 . American Society Anesthesiologists Physical Status IV V 3 . Pulmonary disease necessitate home oxygen therapy 4 . Allergy methadone hydromorphone 5 . Preoperative recent history opioid alcohol abuse 6 . Inability use PCA device speak English language</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>methadone</keyword>
	<keyword>hydromorphone</keyword>
	<keyword>acute postoperative pain</keyword>
	<keyword>chronic persistent surgical pain</keyword>
</DOC>